Metformin may curb depression risk in diabetes patients

12/2/2012 | Diabetes.co.uk (U.K.)

Type 2 diabetes patients who were on metformin treatment had a reduced risk of mood disorders such as depression, as well as Parkinson's disease and dementia, especially if sulfonylurea drugs were used as an add-on therapy, a study from Taiwan showed. The results appear in BMC Medicine.

View Full Article in:

Diabetes.co.uk (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT